Annual CFO
-$347.25 M
-$198.05 M-132.75%
December 31, 2024
Summary
- As of March 13, 2025, BEAM annual cash flow from operations is -$347.25 million, with the most recent change of -$198.05 million (-132.75%) on December 31, 2024.
- During the last 3 years, BEAM annual CFO has fallen by -$280.98 million (-424.00%).
- BEAM annual CFO is now -1641.47% below its all-time high of $22.53 million, reached on December 31, 2022.
Performance
BEAM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$76.36 M
+$11.76 M+13.34%
December 31, 2024
Summary
- As of March 13, 2025, BEAM quarterly cash flow from operations is -$76.36 million, with the most recent change of +$11.76 million (+13.34%) on December 31, 2024.
- Over the past year, BEAM quarterly CFO has increased by +$6.64 million (+8.00%).
- BEAM quarterly CFO is now -134.95% below its all-time high of $218.49 million, reached on March 31, 2022.
Performance
BEAM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$347.25 M
-$211.44 M-155.69%
December 31, 2024
Summary
- As of March 13, 2025, BEAM TTM cash flow from operations is -$347.25 million, with the most recent change of -$211.44 million (-155.69%) on December 31, 2024.
- Over the past year, BEAM TTM CFO has dropped by -$209.78 million (-152.60%).
- BEAM TTM CFO is now -281.99% below its all-time high of $190.80 million, reached on March 31, 2022.
Performance
BEAM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BEAM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -132.8% | +8.0% | -152.6% |
| 3 y3 years | -424.0% | -4272.9% | -424.0% |
| 5 y5 years | -382.3% | -329.0% | -382.3% |
BEAM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1641.5% | at low | -134.9% | +30.5% | -282.0% | +1.8% |
| 5 y | 5-year | -1641.5% | at low | -134.9% | +30.5% | -282.0% | +1.8% |
| alltime | all time | -1641.5% | at low | -134.9% | +30.5% | -282.0% | +1.8% |
Beam Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$347.25 M(+132.7%) | -$76.36 M(-13.3%) | -$347.25 M(+155.7%) |
| Sep 2024 | - | -$88.13 M(+6.2%) | -$135.81 M(-1.2%) |
| Jun 2024 | - | -$83.01 M(-16.8%) | -$137.47 M(-1.2%) |
| Mar 2024 | - | -$99.75 M(-173.8%) | -$139.13 M(-6.7%) |
| Dec 2023 | -$149.19 M(-762.3%) | $135.07 M(-250.4%) | -$149.19 M(-57.8%) |
| Sep 2023 | - | -$89.78 M(+6.0%) | -$353.46 M(+4.5%) |
| Jun 2023 | - | -$84.67 M(-22.9%) | -$338.17 M(+10.6%) |
| Mar 2023 | - | -$109.81 M(+58.7%) | -$305.78 M(-1457.4%) |
| Dec 2022 | $22.53 M(-134.0%) | -$69.19 M(-7.1%) | $22.53 M(-75.9%) |
| Sep 2022 | - | -$74.50 M(+42.5%) | $93.55 M(-45.3%) |
| Jun 2022 | - | -$52.28 M(-123.9%) | $171.05 M(-10.4%) |
| Mar 2022 | - | $218.49 M(>+9900.0%) | $190.80 M(-387.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$66.27 M(-30.8%) | $1.83 M(-39.1%) | -$66.27 M(-28.3%) |
| Sep 2021 | - | $3.01 M(-109.2%) | -$92.40 M(-20.8%) |
| Jun 2021 | - | -$32.53 M(-15.7%) | -$116.62 M(+9.1%) |
| Mar 2021 | - | -$38.58 M(+58.8%) | -$106.93 M(+11.7%) |
| Dec 2020 | -$95.74 M(+33.0%) | -$24.30 M(+14.5%) | -$95.74 M(+7.3%) |
| Sep 2020 | - | -$21.21 M(-7.1%) | -$89.24 M(+5.0%) |
| Jun 2020 | - | -$22.84 M(-16.6%) | -$85.02 M(+15.6%) |
| Mar 2020 | - | -$27.39 M(+53.9%) | -$73.54 M(+2.1%) |
| Dec 2019 | -$72.00 M(+254.7%) | -$17.80 M(+4.8%) | -$72.00 M(+32.8%) |
| Sep 2019 | - | -$16.99 M(+49.7%) | -$54.20 M(+45.7%) |
| Jun 2019 | - | -$11.35 M(-56.1%) | -$37.21 M(+43.9%) |
| Mar 2019 | - | -$25.86 M | -$25.86 M |
| Dec 2018 | -$20.30 M | - | - |
FAQ
- What is Beam Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Beam Therapeutics?
- What is Beam Therapeutics annual CFO year-on-year change?
- What is Beam Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Beam Therapeutics?
- What is Beam Therapeutics quarterly CFO year-on-year change?
- What is Beam Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Beam Therapeutics?
- What is Beam Therapeutics TTM CFO year-on-year change?
What is Beam Therapeutics annual cash flow from operations?
The current annual CFO of BEAM is -$347.25 M
What is the all time high annual CFO for Beam Therapeutics?
Beam Therapeutics all-time high annual cash flow from operations is $22.53 M
What is Beam Therapeutics annual CFO year-on-year change?
Over the past year, BEAM annual cash flow from operations has changed by -$198.05 M (-132.75%)
What is Beam Therapeutics quarterly cash flow from operations?
The current quarterly CFO of BEAM is -$76.36 M
What is the all time high quarterly CFO for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash flow from operations is $218.49 M
What is Beam Therapeutics quarterly CFO year-on-year change?
Over the past year, BEAM quarterly cash flow from operations has changed by +$6.64 M (+8.00%)
What is Beam Therapeutics TTM cash flow from operations?
The current TTM CFO of BEAM is -$347.25 M
What is the all time high TTM CFO for Beam Therapeutics?
Beam Therapeutics all-time high TTM cash flow from operations is $190.80 M
What is Beam Therapeutics TTM CFO year-on-year change?
Over the past year, BEAM TTM cash flow from operations has changed by -$209.78 M (-152.60%)